Diagnosis and management of asymptomatic bacteriuria in kidney transplant recipients: a survey of current practice in Europe

Background Asymptomatic bacteriuria is frequent in kidney transplant recipients (KTRs). However, there is no consensus on diagnosis or management. We conducted a European survey to explore current practice related to the diagnosis and management of asymptomatic bacteriuria in adult KTRs. Methods A panel of experts from the European Renal Association-European Dialysis Transplant Association/Developing Education Science and Care for Renal Transplantation in European States working group and the European Study Group for Infections in Compromised Hosts of the European Society of Clinical Microbiology and Infectious Diseases designed this cross-sectional, questionnaire-based, self-administered survey. Invitations to participate were e-mailed to European physicians involved in the care of KTRs. Results Two hundred and forty-four participants from 138 institutions in 25 countries answered the survey (response rate 30%). Most participants [72% (176/244)] said they always screen for asymptomatic bacteriuria in KTRs. Six per cent (15/240) reported never treating asymptomatic bacteriuria with antibiotics. When antimicrobial treatment was used, 24% of the participants (53/224) said they would start with empirical antibiotics. For an episode of asymptomatic bacteriuria caused by a fully susceptible microorganism and despite no contraindications, a majority of participants (121/223) said they would use a fluoroquinolone (n = 56), amoxicillin/clavulanic acid (n = 38) or oral cephalosporins (n = 27). Conclusions Screening for and treating asymptomatic bacteriuria are common in KTRs despite uncertainties around the benefits and harms. In an era of antimicrobial resistance, further studies are needed to address the diagnosis and management of asymptomatic bacteriuria in these patients.

E. Frangou | P. Kes | K. Lopau | C. Catalano | U. Maggiore | D. Abramowicz | D. Lebeaux | R. Vanholder | L. Peruzzi | T. Fehr | O. Manuel | K. Budde | V. Liakopoulos | P. Mark | B. Bammens | O. Viklicky | E. Thervet | J. Pascual | A. Idrizi | K. Wissing | I. Binet | M. Durlik | P. Messa | T. Mueller | E. Theodoropoulou | C. Viscoli | Thomas Robert | A. Papagianni | B. Suwelack | S. Van Laecke | R. Oberbauer | P. Gibbs | N. Kamar | U. Heemann | J. Steiger | M. Egidi | B. Salzberger | P. Grossi | N. Jourde-Chiche | S. Burtey | G. Oniscu | L. Frimat | P. Brunet | C. Hirzel | P. Lang | M. Helbert | S. Sandrini | L. Hilbrands | S. Knight | D. Kuypers | M. Naesens | Y. Battaglia | P. Phelan | L. Furian | D. Moriconi | P. Muñoz | M. Klinger | E. Pillebout | F. Debellé | P. Gatault | J. Popoola | R. Snanoudj | R. Bonofiglio | D. Anglicheau | M. Dickenmann | M. Giral | M. Pérez-Sáez | M. Crespo | A. Massart | S. Sørensen | K. Hadaya | M. Hazzan | M. Baas | T. Reischig | U. Huynh-Do | R. Lauzurica | C. Legendre | A. Le Moine | R. Hilton | C. Mariat | J. Aguado | L. Guirado | C. Jiménez | A. Mazuecos | D. Hernández | P. Rutkowski | M. Lichodziejewska-Niemierko | Shafi Malik | I. Koneth | M. Fernández-Ruiz | R. San-Juan | G. Mourad | M. Rroji | S. Schaub | I. Étienne | J. Bosmans | N. Bouvier | J. Kanter | É. Cassuto | R. Caldara | D. Somenzi | A. Karras | J. Zuber | C. Hiesse | S. Büttner | T. Baudoux | C. Rafat | A. Hertig | M. Valerio | Pierre-Yves Martin | F. López-Medrano | M. Fariñas | D. Sahali | M. Matignon | H. Akan | Ľ. Drgoňa | B. Zukunft | J. Horcajada | M. Buchler | M. Henckes | Ò. Len | S. Daga | B. Watschinger | K. Ismaili | C. Bistrup | C. Geddes | K. Fourtounas | L. Pipeleers | P. Arnouts | I. Dedinská | B. Sobrino | M. Montejo | M. Veroux | A. Rydzewska-Rosołowska | D. Redondo | S. Thorban | L. Amrouche | L. Couzi | E. Merino | A. Andrés | G. Piotti | V. Garrigue | A. Buscaroli | E. Gheuens | U. Sester | A. Palmisano | F. Marchini | S. Bloudíčková | José Tiago Silva | D. Golshayan | L. Ghisdal | M. Ratković | A. Scemla | R. Pretagostini | J. Hougardy | A. Lemy | E. Mesic | A. Parodi | K. Heller | M. Olmedo | J. Olsburgh | E. Melilli | N. Broeders | M. Magott-Procelewska | H. Vacher-Coponat | E. Psimenou | G. Miserlis | L. Weekers | S. Girerd | L. Zibar | F. Buron | C. Byrne | M. Papasotiriou | G. Spanos | Leyre Martín | E. Nagler | A. Corbel | R. Hellemans | Y. Bouatou | E. Minetti | P. Martín-Moreno | M. Dratwa | P. Errasti | Stéphane Maurel | C. Pleros | Matthew P Welberry Smith | Guilhem Cavaillé | P. Devine | P. Tulissi | P. Braconnier | L. Tricot | P. Madhoun | N. Sabé | H. V. van Hamersvelt | J. Coussement | A. Langlois | B. Adams | J. Puig | Edwin O W Bredewold | A. Zervos | A. Gompou | C. Melexopoulou | I. Berto | M. Michalak | C. Petit-Hoang | O. Ailioaie | Gabriele Guglielmetti | Lídia Santos | M. Nikodimopoulou | A. Nabokow | E. Vigo | G. Tognarelli | C. Mottola | Mireille N. Kianda | H. Kaminski | M. Yague | C. Balgradean | J. Schikowski | C. Agnelli | A. Marega | Y. Tournay | M. Ferrero | D. Kemlin | L. Øzbay | Maria Garjau | B. Schvartz | P. Founta | M. Gerlinger | Anita Krrashi | A. M. Montero | Robert Parry | I. P. Flores | Irena Rambabova Bushljetikj | Roxana Sava | Vibeke Rømming Sørensen | W A G Van Der Meijden | Alain Vandivinit | Nereida Zeneli | L. Santos | R. Parry | F. López‐Medrano | N. Jourde‐Chiche | Caroline Agnelli | Yasmina Tournay

[1]  E. Giménez,et al.  Cytomegalovirus infection management in solid organ transplant recipients across European centers in the time of molecular diagnostics: An ESGICH survey , 2017, Transplant infectious disease : an official journal of the Transplantation Society.

[2]  A. Kribben,et al.  Increased resistance of gram-negative urinary pathogens after kidney transplantation , 2017, BMC Nephrology.

[3]  A. Rodríguez-Benot,et al.  Short-Term Outcome of Untreated Versus Treated Asymptomatic Bacteriuria in Renal Transplant Patients. , 2016, Transplantation proceedings.

[4]  D. Abramowicz,et al.  Old Habits Die Hard: Screening for and Treating Asymptomatic Bacteriuria After Kidney Transplantation , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[5]  J. Aguado,et al.  Should Asymptomatic Bacteriuria Be Systematically Treated in Kidney Transplant Recipients? Results From a Randomized Controlled Trial , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[6]  J. Morales,et al.  Progressive increase of resistance in Enterobacteriaceae urinary isolates from kidney transplant recipients over the past decade: narrowing of the therapeutic options , 2016, Transplant infectious disease : an official journal of the Transplantation Society.

[7]  M. Nucci,et al.  Risk Factors Associated With Early Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: Results From a Multinational Matched Case–Control Study , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[8]  Luke S P Moore,et al.  Antimicrobials: access and sustainable eff ectiveness 2 Understanding the mechanisms and drivers of antimicrobial resistance , 2015 .

[9]  G. Dube,et al.  Epidemiology and outcomes of carbapenem‐resistant Klebsiella pneumoniae bacteriuria in kidney transplant recipients , 2015, Transplant infectious disease : an official journal of the Transplantation Society.

[10]  O. Manuel,et al.  Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  F. Bemelman,et al.  Asymptomatic bacteriuria and urinary tract infections among renal allograft recipients , 2015, Current opinion in infectious diseases.

[12]  A. Webster,et al.  Antibiotics for asymptomatic bacteriuria in kidney transplant recipients. , 2014, The Cochrane database of systematic reviews.

[13]  H. Bang,et al.  Independent Risk Factors for Urinary Tract Infection and for Subsequent Bacteremia or Acute Cellular Rejection: A Single-Center Report of 1166 Kidney Allograft Recipients , 2013, Transplantation.

[14]  O. Manuel,et al.  European survey on the management of tuberculosis in solid‐organ transplant recipients and candidates , 2013, Transplant international : official journal of the European Society for Organ Transplantation.

[15]  K. Julian,et al.  Urinary Tract Infections in Solid Organ Transplantation , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[16]  V. Boddi,et al.  The role of asymptomatic bacteriuria in young women with recurrent urinary tract infections: to treat or not to treat? , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  T. Berney,et al.  Outcome of treated and untreated asymptomatic bacteriuria in renal transplant recipients. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  J. Morales,et al.  Systematic screening and treatment of asymptomatic bacteriuria in renal transplant recipients. , 2010, Kidney international.

[19]  F. Cosio,et al.  The impact of urinary tract infections in renal transplant recipients. , 2010, Kidney international.

[20]  C. van Delden,et al.  Multidrug Resistant Gram‐Negative Bacteria in Solid Organ Transplant Recipients , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  Richard Colgan,et al.  Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  G. Zhanel,et al.  Fluoroquinolone-associated tendinopathy: a critical review of the literature. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. Stephenson,et al.  Routine urinalysis in renal transplant patients. , 1995, Journal of clinical pathology.

[24]  L. Leibovici,et al.  Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: retrospective observational study , 2012, European Journal of Clinical Microbiology & Infectious Diseases.

[25]  A. Oliver,et al.  Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  M. Moradi,et al.  Effect of antibiotic therapy on asymptomatic bacteriuria in kidney transplant recipients. , 2005, Urology journal.